Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Tomas Mikuckis

Partner, Health and Life Sciences, Oliver Wyman

Out-of-Industry Lessons for Healthcare Leaders

Healthcare leaders have much to learn from the retail and aviation industries in their journey to transparency.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Retail and CPG, Oliver Wyman
Partner, Consumer and Industrials, Oliver Wyman

It's time to address the billion dollar telehealth question.

CEO, American Well
Partner, Health and Life Sciences, Oliver Wyman

Personalized, Proactive, and Smarter Care

AI's capability to detect medical conditions early and accurately will disrupt traditional business models.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

The pandemic may transform the foundation that innovative collaborations are based on.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Senior Consultant, Oliver Wyman

How New Price Transparency Rules May Impact Payers and Providers

Immediate considerations for the industry.

Partner, Health and Life Sciences, Oliver Wyman
Global Head, Health Services, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting

Insights in your inbox

Subscribe

Changes are already here, they're real, and we believe they'll scale quickly.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Partner, Digital, Oliver Wyman
Senior Consultant, Oliver Wyman

Despite HHS movement mandating that hospitals estimate patients' bills early on, the thing is, healthcare's already pretty shoppable.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Quality, not quantity, will drive the next wave of partnerships and product launches.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

27 partnered products were launched last year, with 70 percent joint ventured or co-branded insurance products.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

As merger activity heightens, some leverage retail with pharma to meet consumer demand.

Partner, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare
Engagement Manager, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe